sh logo mobile
Stamford Health

NRGOncology-NRG-BR009

Back to Results

A Phase III Adjuvant Trial Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression plus Endocrine Therapy in Premenopausal Patients with pN0-1, ER-Positive/HER2-Negative Brest Cancer and an Oncotype Recurrence Score < 24 - (OFSET)

A Phase III Adjuvant Trial Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression plus Endocrine Therapy in Premenopausal Patients with pN0-1, ER-Positive/HER2-Negative Brest Cancer and an Oncotype Recurrence Score < 24 - (OFSET)

Protocol#: NRG-BR009

 

Contact

Clinical Trials Office at [email protected] or (203) 358-8879.


Principal Investigator(s)

Steve Lo, MD

Sponsor(s)

NRG Oncology Group

Location

Bennett Cancer Center
One Hospital Plaza
Stamford, CT 06902
Main: 203-358-8879

Our website uses cookies

This website uses cookies to give you the very best experience. Your continued use of this site is considered permission by you to use cookies in this manner. Please review our Privacy Policy and Terms of Use for more information about the data we collect and the types of cookies we use. Please note, if you link off our website to a 3rd party site of any kind, that website has its own terms and conditions.

ACCEPT AND CLOSE